Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.9 PLN | +1.67% | +3.58% | -4.52% |
May. 17 | Transcript : Ryvu Therapeutics S.A. - Special Call | |
Mar. 13 | Ryvu Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 89.75M 22.66M | Sales 2025 * | 132M 33.41M | Capitalization | 1.25B 315M |
---|---|---|---|---|---|
Net income 2024 * | -161M -40.65M | Net income 2025 * | -140M -35.35M | EV / Sales 2024 * | 13.6 x |
Net cash position 2024 * | 26.93M 6.8M | Net Debt 2025 * | 65.62M 16.57M | EV / Sales 2025 * | 9.93 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 64.75% |
Latest transcript on Ryvu Therapeutics S.A.
1 day | +1.67% | ||
1 week | +3.58% | ||
Current month | +1.67% | ||
1 month | +5.98% | ||
3 months | -5.83% | ||
6 months | -6.63% | ||
Current year | -4.52% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 06-12-31 | |
Hendrik Nogai
CTO | Chief Tech/Sci/R&D Officer | - | 22-01-31 |
Chief Operating Officer | 38 | 12-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 72 | - | |
Scott Fields
BRD | Director/Board Member | 69 | 23-06-13 |
Thomas Turalski
BRD | Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 54.9 | +1.67% | 3 913 |
24-06-03 | 54 | 0.00% | 1,597 |
24-05-31 | 54 | -0.37% | 2,844 |
24-05-29 | 54.2 | +2.26% | 3,692 |
24-05-28 | 53 | -3.11% | 5,334 |
Delayed Quote Warsaw S.E., June 04, 2024 at 11:55 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.52% | 318M | |
+15.70% | 121B | |
+13.32% | 107B | |
-5.27% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.52% | 15.31B | |
+3.16% | 14.08B | |
+24.32% | 11.74B |
- Stock Market
- Equities
- RVU Stock